Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G.

J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. doi: 10.1093/jnci/djp180. Epub 2009 Jul 2.

3.

Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.

Jang JW, Chun JY, Park YM, Shin SK, Yoo W, Kim SO, Hong SP.

Cancer Sci. 2012 Feb;103(2):296-304. doi: 10.1111/j.1349-7006.2011.02170.x. Epub 2012 Jan 19.

4.

Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G.

Liver Int. 2014 May;34(5):728-36. doi: 10.1111/liv.12313. Epub 2013 Oct 1.

PMID:
24118778
5.

Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.

Tatsukawa M, Takaki A, Shiraha H, Koike K, Iwasaki Y, Kobashi H, Fujioka S, Sakaguchi K, Yamamoto K.

BMC Cancer. 2011 Oct 21;11:458. doi: 10.1186/1471-2407-11-458.

6.

Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.

Park YM, Jang JW, Yoo SH, Kim SH, Oh IM, Park SJ, Jang YS, Lee SJ.

J Viral Hepat. 2014 Mar;21(3):171-7. doi: 10.1111/jvh.12134. Epub 2013 Aug 15.

7.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
8.

Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.

Liao Y, Hu X, Chen J, Cai B, Tang J, Ying B, Wang H, Wang L.

PLoS One. 2012;7(6):e38394. doi: 10.1371/journal.pone.0038394. Epub 2012 Jun 1.

9.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
10.

Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.

Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du Y, Zhao J, Han X, Zhang H, Cao G.

Hepatology. 2013 Jun;57(6):2369-77. doi: 10.1002/hep.26303.

PMID:
23386590
11.

TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.

Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, Groopman J, Chemin I, Hainaut P.

Carcinogenesis. 2012 Jun;33(6):1219-24. doi: 10.1093/carcin/bgs068.

12.

Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.

Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, Lu FM, Zhuang H.

J Gastroenterol. 2007 Sep;42(9):761-8. Epub 2007 Sep 25.

PMID:
17876546
13.

[Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].

Zhang F, Shao YF, Gao JD, Xu Y, Liu GT, Xu LB, Wu ZY, Gao WH, Sun ZT.

Zhonghua Wai Ke Za Zhi. 2007 Nov 1;45(21):1482-4. Chinese.

PMID:
18275715
14.

Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.

Han Y, Pu R, Han X, Zhao J, Zhang Y, Zhang Q, Yin J, Xie J, Shen Q, Deng Y, Ding Y, Li W, Li J, Zhang H, Cao G.

PLoS One. 2013;8(3):e58564. doi: 10.1371/journal.pone.0058564. Epub 2013 Mar 13.

15.
16.

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ; REVEAL-HBV Study Group.

J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.

17.

Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF.

J Infect Dis. 2011 Mar 1;203(5):646-54. doi: 10.1093/infdis/jiq096. Epub 2011 Jan 12.

18.

Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma.

Venard V, Corsaro D, Kajzer C, Bronowicki JP, Le Faou A.

J Med Virol. 2000 Oct;62(2):177-84.

PMID:
11002246
19.

Risk stratification for hepatitis B virus related hepatocellular carcinoma.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.

PMID:
23094699
20.

Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma.

Wong GL, Chan HL, Yiu KK, Lai JW, Chan VK, Cheung KK, Wong EW, Wong VW.

Aliment Pharmacol Ther. 2013 Mar;37(5):517-26. doi: 10.1111/apt.12207. Epub 2013 Jan 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk